Small cell lung cancer and neuroendocrine tumours

Ivelina Pandjarova; Darlene Mercieca; Rolof G P Gijtenbeek; João Oliveira Pereira; Alberto Fantin; Nadia Castaldo; Elli Keramida; Kanwar Pannu; Assia Konsoulova; Avinash Aujayeb

doi:10.1183/20734735.0004-2024

Small cell lung cancer and neuroendocrine tumours

Breathe (Sheff). 2024 Nov 12;20(3):240004. doi: 10.1183/20734735.0004-2024. eCollection 2024 Oct.

Authors

Affiliations

¹ National Cancer Hospital, Sofia, Bulgaria.
² Department of Respiratory Medicine, Mater Dei Hospital Malta, Triq Dun Karm, Malta.
³ Department of Respiratory Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
⁴ Department of Pulmonology, Coimbra Hospital University Centre, Praceta Prof. Mota Pinto, Coimbra, Portugal.
⁵ Department of Pulmonology, University Hospital of Udine (ASUFC), Udine, Italy.
⁶ Sotiria General Hospital of Chest Diseases of Athens, 9th Department of Respiratory Medicine, Athens, Greece.
⁷ Department of Respiratory Medicine, Mid and South Essex NHS Trust, Basildon University Hospital, Basildon, UK.
⁸ Women for Oncology, Bulgaria.
⁹ Department of Respiratory Medicine, Northumbria Healthcare NHS Trust, Cramlington, UK.

Abstract

Lung cancer is one of the leading causes of death worldwide. It can broadly be divided into small cell lung cancer (SCLC) and nonsmall cell lung cancer. There have been many advances over the recent years in both fields. The purpose of this review is to provide a concise summary of SCLC for the general respiratory readership.

Publication types

Review